These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37106170)

  • 21. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV.
    Acharya A; Lynch DL; Pavlova A; Pang YT; Gumbart JC
    Chem Commun (Camb); 2021 Jun; 57(48):5949-5952. PubMed ID: 34019602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
    Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
    Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike.
    Wrobel AG
    Curr Opin Struct Biol; 2023 Aug; 81():102619. PubMed ID: 37285618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
    Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
    J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for raccoon dog receptor recognition by SARS-CoV-2.
    Hsueh FC; Shi K; Mendoza A; Bu F; Zhang W; Aihara H; Li F
    PLoS Pathog; 2024 May; 20(5):e1012204. PubMed ID: 38709834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.
    Ali A; Vijayan R
    Sci Rep; 2020 Aug; 10(1):14214. PubMed ID: 32848162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2.
    Elrashdy F; Redwan EM; Uversky VN
    Infect Genet Evol; 2020 Nov; 85():104510. PubMed ID: 32853823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein.
    Ma S; Li H; Yang J; Yu K
    Biochimie; 2021 Aug; 187():1-13. PubMed ID: 33984400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Piecewise Design Approach to Engineering a Miniature ACE2 Mimic to Bind SARS-CoV-2.
    Vishweshwaraiah YL; Hnath B; Wang J; Chandler M; Mukherjee A; Yennawar NH; Booker SJ; Afonin KA; Dokholyan NV
    ACS Appl Bio Mater; 2024 May; 7(5):3238-3246. PubMed ID: 38700999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel structure-based approach for identification of vertebrate susceptibility to SARS-CoV-2: Implications for future surveillance programmes.
    Kaushik R; Kumar N; Zhang KYJ; Srivastava P; Bhatia S; Malik YS
    Environ Res; 2022 Sep; 212(Pt C):113303. PubMed ID: 35460633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studies.
    Samanta A; Alam SSM; Ali S; Hoque M
    Funct Integr Genomics; 2023 Jan; 23(1):36. PubMed ID: 36631570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.
    Shahbazi B; Mafakher L; Teimoori-Toolabi L
    J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain/ACE2 Complex*.
    Rosario PA; McNaughton BR
    Chembiochem; 2021 Apr; 22(7):1196-1200. PubMed ID: 33174669
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Kumar A; Panwar A; Batra K; De S; Maan S
    Comb Chem High Throughput Screen; 2021; 24(10):1769-1783. PubMed ID: 33172369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor.
    Kim YS; Chung HS; Noh SG; Lee B; Chung HY; Choi JG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
    Rui L; Haonan L; Wanyi C
    Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why Does the Novel Coronavirus Spike Protein Interact so Strongly with the Human ACE2? A Thermodynamic Answer.
    de Andrade J; Gonçalves PFB; Netz PA
    Chembiochem; 2021 Mar; 22(5):865-875. PubMed ID: 33084150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
    Xiang Y; Wang M; Chen H; Chen L
    Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
    Guo X; Chen Z; Xia Y; Lin W; Li H
    J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.